东莞招聘

To increase patient access, delivering greater health impact, and ensuring broader business model innovation增加特殊治疗领域患者准入的解决方案、创新更广泛的业务模式，提供更大的健康事业影响力

Lead and oversee the delivery of high-quality patient programs and activities to improve disease awareness, enhance patient treatment experiences with right partner 选择合格的合作方，主持与监督高质量的患者项目以提高疾病意识，治疗经验

Responsible for all patient programs in compliance with all applicable internal and external policies, procedures and regulations. 并确保这些项目符合内外部政策、流程和规定

• Cooperate with both external partners for instance, Charity organization, patients organization and internal stakeholders such as A&P, Marketing, Medical and GMC on CDI negotiation support, and provide services to the patients in the organization联络外部慈善组织、患者组织对患者的支持以及支持内部（政府事务市场准入部、市场部、医学部）在大病医保中的工作
• Accountable for maintaining a strategic relationship with partners and strong  customer-centric mindset 建立较强的与客户战略合作伙伴关系及客户第一的观念
• Establish the internal capabilities of Patient Program team and develop all necessary SOPs and governance bodies for the function. 遵守合规要求下，开展患者项目
• Design effective processes and tools to optimize patient program design, piloting, full-scale implementation and daily operation; and further to coach and help NGOs capabilities 拥有有效的流程和工具，优化患者项目的实施以进一步提高NGO的能力
• Advise senior management team on matters related to patient programs, insights and risks derived from such programs. 给高层管理团队提供项目相关建议、洞察、风险等
• Coordinate and strengthen the collaborations between patient program with A&P, marketing brand teams, medical affairs and other teams 协调加强内部各部门合作

Build a virtual centre of excellence with different partners to actively encourage good-practice sharing between different patient programs across different brands or therapeutic areas.通过与不同合作方的合作，建立跨治疗领域品牌的卓越的分享平台

辉瑞公司（Pfizer Inc.）创建于1849年，迄今已有160多年的历史，总部位于美国纽约，是目前全球***的以研发为基础的生物制药公司。辉瑞致力于运用创新的科学技术以及全球资源来改善每个生命阶段的健康和福祉。
我们的目标是“不断创新为患者带来能显著改善其健康的药物”。我们的使命是“成为一家卓越的创新型生物制药公司”。
2012年辉瑞公司全年合计收入590亿美元，研发投入78亿美元。辉瑞在全球拥有9万多名员工，59家生产基地，业务遍及全球150多个国家和地区。2012年财富全球500强企业中辉瑞排名126位。
目前辉瑞公司的产品覆盖了包括化学药物、生物制剂、疫苗、健康药物、动物保健品等用于人类、动物和消费者保健等诸多广泛而极具潜力的治疗及健康领域，同时其卓越的研发和生产能力处于全球领先地位。
在人类和动物药品的发现、开发和生产过程中，辉瑞始终致力于奉行严格的质量、安全和价值标准。每天，分布在世界各地的辉瑞员工致力于促进当地医疗卫生的发展以及探索能够应对当今最为棘手疾病的预防和治疗方案。
辉瑞还与世界各地的医疗卫生专业人士、政府和社区合作，支持世界各地的人们能够获得更为可靠和可承付的医疗卫生服务。这与辉瑞作为一家世界领先的生物制药公司的责任是一致的。160多年来，辉瑞一直努力为人们提供更好、更优质的服务。
辉瑞生物制药目前在华上市的创新药物已超过50个，其治疗领域涵盖了心脑血管及代谢、抗感染、中枢神经、抗炎镇痛、抗肿瘤、泌尿、疫苗及等诸多领域。其中如立普妥®、络活喜®、万艾可®、舒普深®、希舒美®、沛儿®、索坦®许多产品在市场上处于领先地位。为了让中国的广大患者能及时接受与全球同步的先进的药物治疗，辉瑞未来将进一步加大和加快在华新药引进和上市的力度和速度。
辉瑞健康药物旗下的善存®、钙尔奇®、惠菲宁®等消费保健产品也在中国市场家喻户晓，并以其优异的品质深受广大消费者的青睐；辉瑞旗下的硕腾动物保健品*为中国的动物保健市场提供各类领先的动物疫苗和动物药品。

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products of healthcare industry and many of the world's best-known healthcare products such as Centrum. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 160 years, Pfizer has worked to make a difference for all who rely on us.